234 related articles for article (PubMed ID: 10655372)
1. Development of a real-time quantitative assay for detection of Epstein-Barr virus.
Niesters HG; van Esser J; Fries E; Wolthers KC; Cornelissen J; Osterhaus AD
J Clin Microbiol; 2000 Feb; 38(2):712-5. PubMed ID: 10655372
[TBL] [Abstract][Full Text] [Related]
2. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
[TBL] [Abstract][Full Text] [Related]
3. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.
Fafi-Kremer S; Brengel-Pesce K; Barguès G; Bourgeat MJ; Genoulaz O; Seigneurin JM; Morand P
J Clin Virol; 2004 Jun; 30(2):157-64. PubMed ID: 15125872
[TBL] [Abstract][Full Text] [Related]
4. Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus-Positive T-Cell/Natural Killer Cell Lymphoproliferative Diseases.
Kawada JI; Kamiya Y; Sawada A; Iwatsuki K; Izutsu K; Torii Y; Kimura H; Ito Y
J Infect Dis; 2019 Sep; 220(8):1307-1311. PubMed ID: 31240305
[TBL] [Abstract][Full Text] [Related]
5. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
[TBL] [Abstract][Full Text] [Related]
6. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.
Jamalidoust M; Geramizadeh B; Pouladfar G; Namayandeh M; Asaie S; Aliabadi N; Nikeghbalian S; Ziyaeyan M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():306-11. PubMed ID: 25894179
[TBL] [Abstract][Full Text] [Related]
8. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.
Baldanti F; Grossi P; Furione M; Simoncini L; Sarasini A; Comoli P; Maccario R; Fiocchi R; Gerna G
J Clin Microbiol; 2000 Feb; 38(2):613-9. PubMed ID: 10655355
[TBL] [Abstract][Full Text] [Related]
9. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA.
Hill CE; Harris SB; Culler EE; Zimring JC; Nolte FS; Caliendo AM
Am J Clin Pathol; 2006 May; 125(5):665-71. PubMed ID: 16707366
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children.
Pitetti RD; Laus S; Wadowsky RM
Pediatr Infect Dis J; 2003 Aug; 22(8):736-9. PubMed ID: 12913777
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
[TBL] [Abstract][Full Text] [Related]
15. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
16. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
Stevens SJ; Pronk I; Middeldorp JM
J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
[TBL] [Abstract][Full Text] [Related]
17. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.
Gulley ML; Fan H; Elmore SH
J Mol Diagn; 2006 Nov; 8(5):589-97. PubMed ID: 17065428
[TBL] [Abstract][Full Text] [Related]
18. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells.
Wagner HJ; Jabs W; Smets F; Wessel M; Fischer L; Offner G; Kirchner H; Bucsky P
Klin Padiatr; 2000; 212(4):206-10. PubMed ID: 10994552
[TBL] [Abstract][Full Text] [Related]
19. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
Scheenstra R; Verschuuren EA; de Haan A; Slooff MJ; The TH; Bijleveld CM; Verkade HJ
Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222
[TBL] [Abstract][Full Text] [Related]
20. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
Jabs WJ; Hennig H; Kittel M; Pethig K; Smets F; Bucsky P; Kirchner H; Wagner HJ
J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
